作者:Serena Massari、Dirk Daelemans、Giuseppe Manfroni、Stefano Sabatini、Oriana Tabarrini、Christophe Pannecouque、Violetta Cecchetti
DOI:10.1016/j.bmc.2008.11.056
日期:2009.1
The 6-desfluoroquinolones which have been developed by our group represent a promising class of compounds for the treatment of HIV infection since they act on transcriptional regulation, a crucial step in the replication cycle that has not been clinically exploited, yet. Focussing attention on the N-1 and C-6 positions, a novel series of quinolones has been synthesized. New SAR insights have been obtained, in particular, the hydroxyl group emerged as a suitable C-6 substituent when coupled with the appropriate arylpiperazine at the neighboring C-7 position. (C) 2008 Elsevier Ltd. All rights reserved.